COH logo

Cochlear Limited Stock Price

ASX:COH Community·AU$6.7b Market Cap
  • 4 Narratives written by author
  • 1 Comments on narratives written by author
  • 77 Fair Values set on narratives written by author

COH Share Price Performance

AU$0
-269.55 (-100.00%)
AU$70.00
Fair Value
AU$0
-269.55 (-100.00%)
Price AU$0

COH Community Narratives

Fair Value
·
Fair Value AU$70 49.9% overvalued intrinsic discount

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

0users have liked this narrative
1users have commented on this narrative
4users have followed this narrative
·
Fair Value AU$124.6 15.8% undervalued intrinsic discount

Aging Population Will Spur Cochlear Implant Adoption Worldwide

1users have liked this narrative
0users have commented on this narrative
36users have followed this narrative
·
Fair Value AU$210 50.0% undervalued intrinsic discount

Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
COH logo
Cochlear

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

Cochlear Limited is an interesting company. It is a medical technology business with a specific focus on implantable hearing solutions.Read more

View narrative
AU$70
49.9% overvalued intrinsic discount
Fair Value
Revenue
0.14% p.a.
Profit Margin
14.77%
Future PE
18.92x
Price in 2031
AU$100.4
AU$124.6
15.8% undervalued intrinsic discount
Revenue
4.41% p.a.
Profit Margin
15.15%
Future PE
24.93x
Price in 2029
AU$153.5
AU$210
50.0% undervalued intrinsic discount
Revenue
7.45% p.a.
Profit Margin
18.3%
Future PE
32.2x
Price in 2029
AU$261.18
AU$350
70.0% undervalued intrinsic discount
Revenue
14.36% p.a.
Profit Margin
20.5%
Future PE
39.58x
Price in 2029
AU$435.04

Trending Discussion

Updated Narratives

COH logo

Cochlear’s Crossroads: Temporary Setback or Structural Shift?

Fair Value: AU$70 49.9% overvalued intrinsic discount
4 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative
COH logo

COH: Margin Resilience And Temporary Volume Weaknesses Will Support Future Upside

Fair Value: AU$124.6 15.8% undervalued intrinsic discount
36 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
COH logo

Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability

Fair Value: AU$210 50.0% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

1 Risk
3 Rewards

Cochlear Limited Key Details

AU$2.3b

Revenue

AU$636.9m

Cost of Revenue

AU$1.7b

Gross Profit

AU$1.4b

Other Expenses

AU$345.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
5.28
72.76%
14.77%
0.7%
View Full Analysis

About COH

Founded
1981
Employees
5500
CEO
Diggory Howitt
WebsiteView website
www.cochlear.com

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.

Recent COH News & Updates

Narrative Update Jun 03

COH: Margin Resilience And Temporary Volume Weaknesses Will Support Future Upside

The analyst price target for Cochlear has eased slightly from about A$126.08 to A$124.60, as analysts factor in more moderate revenue growth expectations alongside marginally stronger profit margins and a slightly lower assumed future P/E, following mixed recent research views. Analyst Commentary Bullish Takeaways Bullish analysts see room for upside if Cochlear can deliver on revenue expectations while maintaining the marginally stronger profit margins now being reflected in models.
Narrative Update May 09

COH: Steadier Growth Assumptions Will Support Future Upside If Execution Holds

The updated analyst price target for Cochlear has shifted from A$239.95 to A$126.08 as analysts incorporate more moderate assumptions for revenue growth, profit margins and future P/E. This reflects mixed recent research views from Citi and Morgan Stanley.

Recent updates

No updates